Anti-MAG antibody-associated polyneuropathies: improvement following immunotherapy with monthly plasma exchange and IV cyclophosphamide

Neurology
G BlumeL T Goodnough

Abstract

Treatment outcomes of sensory-motor polyneuropathies associated with anti-myelin-associated glycoprotein (MAG) antibodies have varied even with relatively intensive immunosuppression. We used plasma exchange and cyclophosphamide to treat four patients with anti-MAG antibody-associated polyneuropathies whose symptoms had progressed in the preceding year. Treatment courses consisted of five to seven monthly regimens of plasma exchange on 2 consecutive days followed by intravenous cyclophosphamide (1 g/m2). Effects of treatment were quantitatively measured with hand-held dynamometry. All four patients showed improvement in both strength and sensation in the 5 to 24 months after treatment. We conclude that selected patients with sensory-motor polyneuropathies associated with high-titer serum IgM autoantibodies against MAG may have quantitative and useful functional improvement after immunotherapy. The improvement continues after completion of treatment and may persist for 1 to 2 years or longer.

Citations

Oct 27, 1997·Muscle & Nerve·G I WolfeR J Barohn
Apr 15, 2000·Journal of Clinical Apheresis·R Weinstein
Aug 10, 2000·Italian Journal of Neurological Sciences·G Comi, L Roveri
Apr 19, 2005·Journal of Neurology·Eduardo Nobile-Orazio
Jan 16, 2007·Current Neurology and Neuroscience Reports·Thomas B Toothaker, Thomas H Brannagan
Feb 17, 2001·Current Treatment Options in Neurology·Matthew P. Wicklund, John T. Kissel
Jan 6, 2000·Transfusion Science·J M Léger
Feb 27, 2001·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·S AttarianJ Pouget
May 29, 1998·The New England Journal of Medicine·A H Ropper, K C Gorson
Mar 1, 2006·Journal of Clinical Neuromuscular Disease·Norman LatovJean Michel Vallat
Apr 21, 1999·Journal of Neurology, Neurosurgery, and Psychiatry·H C WilsonR A Hughes
Mar 18, 2003·Journal of Neurology, Neurosurgery, and Psychiatry·A PestronkT D Levine
Jun 23, 2011·Therapeutic Advances in Neurological Disorders·Min-Suk YoonRalf Gold
Jul 26, 2011·Proceedings of the Japan Academy. Series B, Physical and Biological Sciences·Toshio Ariga
Jul 21, 2010·Neurology India·Kamakshi PatelSuraj Ashok Muley
Sep 22, 2005·Current Rheumatology Reports·Lisa D Hobson-Webb, Peter D Donofrio
Aug 16, 2013·Immunopharmacology and Immunotoxicology·Nizar SouayahPeter Siao Tick-Chong
Nov 3, 2006·Expert Review of Neurotherapeutics·Yee-Cheun Chan, Einar Wilder-Smith
Jul 16, 2009·Expert Opinion on Pharmacotherapy·Laurent Magy, Jean-Michel Vallat
Jan 8, 2005·Clinical Lymphoma·Jan Drappatz, Tracy Batchelor
Feb 28, 2007·Neurologic Clinics·Justin Y Kwan
Nov 18, 2015·Journal of Neuropathology and Experimental Neurology·Rina HashimotoGen Sobue
Apr 23, 2003·Muscle & Nerve·Susanne RenaudAndreas J Steck
Aug 21, 2003·Muscle & Nerve·Peter D Donofrio
May 28, 2008·Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·Jürgen RechHendrik Schulze-Koops
Aug 2, 2006·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·UNKNOWN European Federation of Neurological SocietiesI N van Schaik
Nov 1, 2013·British Journal of Haematology·Hollie M Reeves, Jeffrey L Winters
Jul 4, 2006·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Takahisa GonoShu-ichi Ikeda
Jun 13, 2015·Journal of Immunology Research·Laurent MagyJean-Michel Vallat
May 18, 2016·The International Journal of Neuroscience·Giuliana GalassiFranco Valzania
Jun 9, 2016·Expert Review of Neurotherapeutics·Jean-Michel VallatStéphane Mathis
Jan 5, 2002·Neurologic Clinics·Edward J Dropcho

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.